SKIN DISEASES
Clinical trials for SKIN DISEASES explained in plain language.
Never miss a new study
Get alerted when new SKIN DISEASES trials appear
Sign up with your email to follow new studies for SKIN DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could ifetroban ease scleroderma lung damage?
Disease control OngoingThis study tests an experimental drug called ifetroban in people with a severe form of scleroderma (diffuse cutaneous systemic sclerosis) or scleroderma-related high blood pressure in the lungs. The goal is to see if the drug is safe and can improve lung function. About 34 adults…
Matched conditions: SKIN DISEASES
Phase: PHASE2 • Sponsor: Cumberland Pharmaceuticals • Aim: Disease control
Last updated May 05, 2026 11:55 UTC
-
AI takes on skin docs: who diagnoses better?
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at whether artificial intelligence (AI) can give the same skin disease diagnosis as a skin doctor (dermatologist). Researchers will review 1000 adults whose general practitioner sent a photo and question to a dermatologist through a special platform. They will co…
Matched conditions: SKIN DISEASES
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated May 17, 2026 02:06 UTC
-
Scientists hunt for the 'molecular scar' that makes psoriasis come back
Knowledge-focused OngoingThis study looks at why psoriasis tends to return even after skin looks healed. Researchers think special immune cells (tissue-resident memory T cells) may act like a 'memory' of the disease. They are testing whether combining a medicated foam (Enstilar®) with narrow-band UVB lig…
Matched conditions: SKIN DISEASES
Phase: PHASE4 • Sponsor: Aarhus University Hospital • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC